Introduction: Dengue virus (DENV) is the arbovirus with the widest impact on human health. In Africa in general, and in Angola in particular, the epidemiology and public health impact of DENV is far from clear. However, rapid population growth, unplanned urbanization, increased international travel, and the presence of virus major vector (Aedes aegypti) in the country suggest that DENV transmission may occur. Methodology: In parallel to the occurrence of a dengue outbreak affecting the capital of Angola, between March and July 2013 four Portuguese institutions diagnosed dengue infection in 146 individuals returning to Portugal. Clinical presentation, laboratory findings, and molecular analyses of partial viral genomic segments were performed. Results: The mean age of the individuals included in this study was 42 years old, the majority being men of Portuguese nationality, reporting various lengths of stay in Angola. Fever was the most reported clinical sign, being frequently associated (61.0%) with myalgia and headache. Hematological values, including hematocrit, white-blood cell and platelets counts, correlated with the absence of severe or complicated cases, or coagulation disorders. No deaths were observed. Viral NS1 was detected in 56.2% of the samples, and all NS1 negative cases had antidengue IgM antibodies. RT-PCR indicated the presence of DENV1, which was confirmed by phylogenetic analysis of 25 partial NS5 viral sequences. Conclusion: The DENV cases analyzed conformed to classical and uncomplicated dengue, caused by the suggested exclusive circulation of a genetically homogeneous DENV1 of genotype III, apparently with a single origin.
In recent decades, dengue virus (DENV) has emerged as a worldwide public health problem. Although its real impact on human health is difficult to assess, estimates refer that 50-400 million infections may occur worldwide annually [1, 2] . The majority of these are asymptomatic, and symptomatic cases present as an acute and abrupt febrile syndrome (classical dengue or dengue fever). However, some may evolve to potential life threatening clinical presentations (dengue hemorrhagic fever/dengue shock syndrome) with a case-fatality rate of 0.1%-5% [3] .
The geographical distribution of the DENVinfections is not homogeneous, the majority occurring in the Asia-Pacific and Americas-Caribbean regions [1] . In Africa, the epidemiology and public health impact of dengue is far from clear, but the wide geographical distribution of the virus's primary invertebrate vectors (Aedes aegypti and Aedes albopictus), rapid population growth, unplanned urbanization, and increased international travel, make the transmission of DENV very likely [4] . However, since malaria is endemic in most of the African continent, the great majority of febrile illnesses are diagnosed and treated as such, often without proper medical examination or laboratory confirmation [5] . In fact, serological surveys conducted in Burkina Faso [6] have suggested that dengue may be more prevalent in Africa than generally recognized.
In the context of an outbreak of dengue, first reported by the Angolan health authorities on the 1 st of April 2013 [7] , a total of 146 dengue cases were identified in four Portuguese medical institutions between the 1 st of March and the 12 th of July, with a peak number of dengue cases in May (n = 70). These institutions included the Institute of Hygiene and Tropical Medicine (IHMT) and the Egas Moniz Hospital (HEM) in Lisbon, the University Hospital S. João (HSJ) in Oporto and the University Hospital (CHUC) in Coimbra. The mean age of the 146 individuals included in this study was 42 years old (ranging from 21 to 69 years), with 78.8% (n = 115) men (mean = 42.5 years, ranging from 22 to 69) and 21.2% (n = 31) women (mean = 40.2 years, ranging from 21 to 66). The majority (81.5%, n = 119) were of Portuguese nationality, the second most represented nationality was Angolan (7.5% n = 11), while 5 individuals reported double nationality (3.4%). Finally Spanish, Moldavan, and Romanian origin was reported once (each). Length of stay in Angola lasting up to 1 month was reported by 14 individuals, while 55 and 73 indicated having stayed in Angola ≤ 6 months, and >7 months, respectively.
Dengue case definition included a suggestive clinical presentation (high fever, accompanied by two additional symptoms including severe headache, retroorbital pain, muscle and joint pains, nausea, vomiting, swollen glands or rash, as defined by WHO [1] , along with a positive rapid diagnostic test (RDT). RDT results obtained, describing the detection of NS1 antigen, anti-DENV IgM and IgG antibodies, are collectively described in Figure 1 . Cases with only anti-DENV IgG antibodies were excluded from the analysis. Fever was the most frequently reported clinical sign (n = 133/91.0%), lasting, in the majority (70.2%) of the cases (59 out of 84 for which the feverish period was recorded) between 4 and 7 days. The frequency of registered symptoms and signs is indicated in Table 1 . The characteristic combination of fever, myalgia and headache was present in 61.0%. No clinical evidence of coagulation disorder was observed. Malaria was ruled out in febrile patients either by direct examination (at the CHUC) or by direct examination and Plasmodium sp. RDT (at IHMT, HEM, HSJ). In 8 cases, a malaria test was performed in another institution. In 5 additional patients, malaria was excluded based only on clinical grounds (e.g. incubation period or previous recent malaria treatment in Angola). Hematological data is shown in Table 2 . The values indicating the average amount of hemoglobin and hematocrit together with white-blood cell and platelets counts correlated with the absence of severe or complicated cases, as defined by WHO [1] . No deaths were observed. Viral NS1 was detected in 56.2% of the samples (n = 82). All NS1 negative cases (n = 33) had antidengue IgM antibodies. In the 31 cases where NS1 detection was not carried out, 29 showed IgM and IgG anti-dengue antibodies, whereas 2 cases had only IgM (Figure 1) .
Detection of viral RNA was carried out by nested RT-PCR using primers D1 and D2 in the first-round and D1 with a mixture of subtype-specific reverse primers (TS1-4) in a multiplex second-round, as previously reported [8] . We analyzed a total of 25 samples (out of 29), the majority (n = 24) also evidenced NS1 by RDT. As previously reported by IHMT [9] , and in accordance to previously published studies [10] the amplicons size was compatible with only the presence of DENV1. Molecular confirmation was obtained by phylogenetic analysis of either C-prM (accession numbers HG515502-09) of NS5 (accession numbers HG515510-27) sequences, amplified using primers 1NS5F/1NS5R (first-round) and 2NS5F/2NS5R (second-round) as previously described [11] . The preliminary analysis of the obtained sequences (Figure 2) clearly indicates a segregation of the Angolan DENV sequences (collectively grouped as Angola 2013 ) in a consistent monophyletic cluster (bootstrap value of 100) within the DENV1 radiation (supporting the preliminary viral subtype assignment based on RT-PCR data), in association to a viral sequence of African origin (Cote d'Ivoire Abijan ). Subsequently, a more robust Bayesian phylogenetic analysis (Figure 3 ) again confirmed, with maximum posterior probability, the monophyletic origin of the Angolan and Cote d'Ivoire sequences. Furthermore, the cluster formed by the Angolan sequences was characterized by low genetic variability, suggesting the circulation of viral strains sharing a common origin. As expected, the analysis of the putative products encoded by these sequences revealed overall sequence conservation, with only one nonconservative difference (indicated by the / symbol in Figure 4 ) between the Angolan 2013 Dengue NS5 sequence cluster and that of its most closely related viral strain (Cote d'Ivoire Abidjan , AF298807). Aedes aegypti was identified in Angola in 1903, 1956 and 1973 [12-14] . Both serological reports from the 1960s [15] , and the detection of DENV1 and DENV2 in travelers in the 1980s and in 1999/2002 [16, 17] suggest long lasting endemic DENV activity in the country. The origin of the DENV that was responsible for the outbreak in Luanda has been difficult to assess, and even the genetic analysis of the whole viral sequence [10] has not deemed possible a conclusive identification of its source, most probably due to limited sampling of viral strains of African origin. In turn, this consequently compromises subsequent genetic analyses.
The real number of dengue cases in Africa is surely under-reported due to i) low awareness of the medical community/health-care providers, ii) lack of laboratory testing, and iii) poor/nonexistent surveillance programs. In this context, travelers returning to their countries may serve as possible sentinels to local epidemics, especially in areas of the globe where surveillance of infectious agents is compromised. This issue is all the more relevant if we take into account the fact that a recent study indicated that approximately 16% of the total worldwide DENV infections occur in sub-saharan Africa [4] . Relevant to our analysis is the fact that DENV has been repeatedly found in travelers/expatriates returning from countries that border Angola such as the Democratic Republic of Congo and Namibia, although approximately half of the African countries where travelers had been infected with dengue do not report any local viral activity [4] .
Long-distance travelers may allow the indirect reporting of transmission of infectious agents in areas where local detection is technically and/or financially unfeasible. Additionally, they may also serve as seeders of new outbreaks in case a viremic status is maintained upon arrival to their final destinations. Accordingly, the virus was detected in Germany, Canada, France, South-Africa and Israel [18] . In the context of Angola's 2013 outbreak, we were able to readily detect viral genomes by RT-PCR from Dengue-NS1reactive sera. This raises concerns regarding the potential endemic circulation of DENV in the territory, especially when a very recent report disclosed the presence of DENV in Luanda [19] , as well as for establishment of epidemic foci in regions with active populations of Ae. aegypti and/or Ae. Albopictus (e.g. Madeira Island and several countries in the Mediterranean basin) [20] , opening the possibility for local virus introduction and dissemination from distant epidemic foci.
